Pharma Journalist - Page 54 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Atombeat and BioDuro Partner to Launch AI Platform for Faster Peptide Drug Discovery

Sandoz to Acquire Just-Evotec Biologics Facility in Toulouse Under New Term Sheet

Repligen and Novasign Partner to Drive Bioprocessing Digitalization

Altasciences and VoxCell Partner to Boost Preclinical Drug Development

Lilly’s Mounjaro Shows Heart Benefits in Landmark Trial for Type 2 Diabetes Patients

AstraZeneca and Revna Biosciences Expand Lung Cancer Treatment Access in Ghana

Viridian and Kissei Partner to Develop Veligrotug and VRDN-003 in Japan in $385M Deal

ViroCell and AvenCell Partner on Retroviral Vector Manufacturing for Next-Gen CAR-T Blood Cancer Therapies

Madrigal Pharmaceuticals Secures Exclusive Global License for Oral GLP-1 Agonist with CSPC Pharmaceutical

Strategic Partnership Formed with Allianthera (Suzhou) Biopharmaceuticals